3rd Quarter - Report

C2 GROUP, LLC for PERRIGO INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Monitor tax reform.

LobbyistCovered position, as disclosed
THOMAS CRAWFORD —
GALEN J RESER Asst. Secretary for Govt. Affairs at DOT
DAVID PATRICK ROBERTSON Leg. Aide & Leg. Correspondent, Senator Rockefeller

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Dextromethorphan, Pseudoephedrine restriction issues.

LobbyistCovered position, as disclosed
THOMAS CRAWFORD —
GALEN J RESER Asst. Secretary for Govt. Affairs at DOT
DAVID PATRICK ROBERTSON Leg. Aide & Leg. Correspondent, Senator Rockefeller

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. GDUFA H.R.5651, S.3187.

LobbyistCovered position, as disclosed
THOMAS CRAWFORD —
GALEN J RESER Asst. Secretary for Govt. Affairs at DOT
DAVID PATRICK ROBERTSON Leg. Aide & Leg. Correspondent, Senator Rockefeller

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 312 (112th), S. 3187 (112th), H.R. 5651 (112th), H.R. 605 (112th), H.R. 3630 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.